Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LPA Protein (AA 1719-2038) (His tag)

APOA Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by reducing SDS-PAGE.
Produktnummer ABIN7505620
  • Target Alle LPA (APOA) Proteine anzeigen
    LPA (APOA) (Apolipoprotein A (APOA))
    Protein-Typ
    Recombinant
    Proteineigenschaft
    AA 1719-2038
    Spezies
    Human
    Quelle
    • 1
    • 1
    • 1
    HEK-293 Cells
    Aufreinigungstag / Konjugat
    Dieses LPA Protein ist gelabelt mit His tag.
    Sequenz
    Asp1719-Arg2038
    Produktmerkmale
    A DNA sequence encoding the Human LP-a protein (P08519) (Asp1719-Arg2038) was expressed with a C-His.
    Reinheit
    > 95 % as determined by reducing SDS-PAGE.
    Top Product
    Discover our top product APOA Protein
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    Lyophilized from sterile PBS, pH 7.4.
    Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween80 are added as protectants before lyophilization.
    Lagerung
    4 °C,-20 °C,-80 °C
    Informationen zur Lagerung
    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
    Haltbarkeit
    12 months
  • Target
    LPA (APOA) (Apolipoprotein A (APOA))
    Andere Bezeichnung
    Lipoprotein A (APOA Produkte)
    Synonyme
    AK38 Protein, APOA Protein, LP Protein, Apo(a) Protein, Lp(a) Protein, lipoprotein(a) Protein, LPA Protein
    Hintergrund

    Abbreviation: Apolipoprotein,Lp

    Target Synonym: APOA,Apolipoprotein(a),Apo(a),Lp(a),LPA,Lp(a)

    Background: Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330.Apo(a) is known to be proteolytically cleaved, leading to the formation of the so-called mini-Lp(a). Apo(a) fragments accumulate in atherosclerotic lesions, where they may promote thrombogenesis. O-glycosylation may limit the extent of proteolytic fragmentation. Homology with plasminogen kringles IV and V is thought to underlie the atherogenicity of the protein, because the fragments are competing with plasminogen for fibrin(ogen) binding.

    Molekulargewicht

    Calculated MW: 35.09 kDa

    Observed MW: 35 kDa

    UniProt
    P08519
Sie sind hier: